We describe a new method for quantitatively measunng substances of clinical interest by high-performance liquid affinity chromatography (HPL.c).As a model system we selected analysis for transferrin in human serum with immobilized antibodies in a high-performance liquid chromatographic system. SelectiSpher-1 0 Activated Tresyl columns (5 or 10 x 0.5 cm) were used for in situ coupling of polyclonal antibodies to transfernn. The amount of transferrin eluted was determined by integratingthe eluted peak at 280 nm. The whole analyticalprocedure-including injectionof sample, washing,elution,and analysisof data-takes only7 mm. We characterized the HPLAC system for analysis of transfernn in several ways: intra-assay CV -3%; inter-assay CV 2-9%; linear response up to 1 mg/mL column volume; detection limit -3 dig; analytical recovery 98% ± 2%; purity of eluted sample >95% (SOS-PAGE). The HPLAC method was compared with "rocket" immunoelectrophoresis,a commonly used method of analysis for transferrin, and there was excellent correlation between the two methods (r= 0.96, n = 60). were improved in terms of speed, resolution, and analytical recovery of product (4)#{149}3 The very rapid separations possible with m'iAc should encourage the use of affinity chromatography for routine clinical chemistry laboratory quantification of proteins and metabolites.
Since its early developments in the 1970s, affinity chromatography has become an established tool for isolating biomolecules (1, 2). Many enzymes and other proteins such as antibodies have been purified from crude samples by this technique. With the introduction of high-performance liquid affinity chromatography (HP1.&c) (3), where small (-10 sum), noncompressible particles are used as supports for affinity chromatography, separations were improved in terms of speed, resolution, and analytical recovery of product (4)#{149}3 The very rapid separations possible with m'iAc should encourage the use of affinity chromatography for routine clinical chemistry laboratory quantification of proteins and metabolites.
This has been supported by several reports (5) (6) (7) , but only some of these have addressed questions of accuracy, reproducibility, and stability in sufficient detail to make obvious their analytical applicability
(8).
Here, we investigated the potential of using m'iAc for clinical determination of transferrin in human serum. Transferrin, the major iron-binding protein in plasma, is of clinical interest in assessment of iron metabolism, e.g., in
iron-deficiency anemia.
The m'ic procedure developed herein based on the use of silica-bound anti-transferrin antibodies. Results of this procedure correlated closely with "rocket" immuncelectropho-'Perstorp Biolytica AB, S-223 70 Lund, Sweden. 2Department of Pure and Applied Biochemistry, Chemical Contar, University of Lund, S-221 00 Lund, Sweden.
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reals (RIE) determinations
of transferrin. The procedure was easily automated.
Materials and Methods

Materials
The 
Chromatography Apparatus
The HPLC system was a Varian LC 5500 with a UV-200 detector and autosampler (Varian, Walnut Creek, CA). The system was equipped with a Model CR 3A integrator (Shimadzu, Kyoto, Japan).
Procedures
Preparation of immunosorbent
(typical procedure). Covalent binding of antibodies to the support was carried out in situ according to the manufacturer's instructions.
All
procedures were carried out at room temperature 
Determination of binding capacity of immunosorbent.
Human TF, 1 mglmL dissolved in 0.1 mol/L NaH2PO4 buffer, anti-TF column was used at room temperature (20230C), with a flow rate of 3 mL/min. Before analysis, serum samples were centrifuged or ifitered (0.45-sm pore-size filter). We injected 50-i.L samples onto the anti-TF urIc column with sodium phosphate (0.1 moJJL, pH 7.4) as the binding buffer. After washing with 0.1 mol/L citric acid reagent, pH 4.5, we eluted transferrin with a pH 1.3 mixture of citric acid (0.1 mol/L) and isopropanol (100 g/L) (see Figure 2 ).
Rocket immunoelectrophoresis (RIE).
As the comparison method, we used RIE according to Laurell (9), with the same standards and antibodies as in the irnAc-procedure.
RIE is widely used as a routine method for determination of transferrin in serum. Electrophoretic analysis. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) was performed essentially as described by Laemmli (10) with use of a 4% stacking gel and a 12% separation gel. Gels were stained with silver. The following proteins were used as molecularmass standards: transferrin 
RIE compared for measurement
of TF in serum. Serum samples from 60 patients were assayed by mi.Ac (with the 5 x 0.5 cm column) with Seronorm as the standard under the conditions described under Final analytical procedure. The pressure drop during the analytical cycle ranged from 3800 to 5600 kPa when the buffer solution was changed. Every sample was analyzed in duplicate and,between each sample application, the whole injection system was washed with mobile phase. We occasionally injected buffer with no sample, to check the elution system. The 60 samples were also analyzed by RIE on a single-blind basis. Least-squares regression analysis was used to calculate slope and intercept of the line of best fit through the data points.
Results and Discussion
The aim of this studywas to evaluate the general applicability of Iwi.kc in clinical chemical analysis and we considered determination of transferrin in serum to be a suitable system to study, for several reasons. Normally transferrin is present in serum at about 2 mg/mL, a concentration that would make feasible a reliable, direct quantification by ultraviolet detection. This requires a chromatographic system with a high selectivity for transferrin.
Because antitransferrin antibodies were readily available, the prerequisites for a successful HPIA system were at hand. In the following we describe the preparation of immunoadsorbent and determination of its operational binding capacity and stability, followed by the design of a reliable protocol for transferrin analysis, including comparisons with an established method for determination of transferrin.
Preparationof immunoadsorbent
The antibodies of TF were coupled in situ to the activated tresyl column merely by pumping the antibodies through the column. Figure 1 shows the ultraviolet profile of the binding process. The loading capacity was calculated to be 40mg of antibodies per milliliter of column volume. Because we were using the whole antibody fraction of a rabbit antiserum to human TF, only a minor fraction of the bound antibodies were directed to TF, 4-8% as calculated from the manufacturer's specifications. The efficiency and speed of coupling of antibodies can be seen in Figure 1 . The total coupling procedure was complete 
Operational Binding Capacity of immunoadsorbent
Purified human TF (1 mg/mL) was continuously pumped through the column at 1 mlimin until the column packing became saturated. The column was then washed extensively and bound TF was eluted with 0.1 mol/L citric acid, pH 2.2. From this, we calculated the capacity of the columns to be 2.5-3 mg of TF per milliliter (5 cm of column = 1 mL). No TF was bound to a column containing no antibodies. The capacity for TF suggests high analytical recovery (>50%) of active antibodies to TF immobilized on the columns. This calculation is based on an antibody content of 40 mg per milliliter of column volume, the fraction of anti-transferrin antibodies (4-8%), the molecularmasses of IgG and transferrin(150 000 Da and 81 000 Da, respectively), and a binding stoichiometry of 1:2. However, the overall stoichiometry in the column between antigen and antibody and the exact amount of polyclonal anti-TF antibodies are uncertain, so these assertions are only intended as an approximation.
Design of the Analytical System
To develop an efficient analytical procedure (in terms of speed, sensitivity, and reproducibility), we thoroughly investigated some chromatographic variables. We soon realized that neutral buffers such as 0.1 mol/L phosphate in the pH range 7-7.5 were suitable for application of samples. However, the elution procedure presented problems in early experiments.
Because we were using polyclonal antibodies characterized by heterogeneous and "high"-afllnity interactions between antibody and antigen, we investigated some harsh elution conditions such as low pH, high concentrations of salt, and chaotropic ions. In addition, because we wanted to use an ultraviolet monitor for detecting eluted substances, the choice of elution agents was somewhat limited. Elution with 0.1 mol/L citrate buffer, pH 1.3, was efficient. However, the choice of pH and formulation of buffers was critical; e.g., phosphate and glycine buffers at low pH could not totally elute the bound TF. Also, the drop in pH when elution is started needed to be as rapid as possible to inhibit band broadening of elutedpeaks. Therefore, for results to be reproducible, it was essential to keep the pH of the eluting buffer consistent during the elution (PH = 1.30 ± 0.05). Use of a high salt concentration such as
NaC1 at 0.5-i mol/L or chaotropic ions (such as CF3COO)
did not improve the elution proffle. However, increasing the hydrophobic character of the elution buffer by adding isopropanol influenced performance favorably.
The optimized chromatographic scheme for analysis of human transferrin is shown in Figure 2 . An intermediate elution buffer was inserted (B in Figure 2 ) to obtain a fast decrease in pH, even when the system was automated. On the other hand, application of serum samples in buffer B
( Figure   2 ) resulted in extensive washing out of loosely bound material. No "ghost" peaks were observed with the selected elution conditions. An analytical cycle, including system regeneration, lasts 5 to 7 mm, depending on the amount of sample injected.
Characterization of Analytical System
Standard curves and linearity. We constructed standard curves by plotting the response from the ultraviolet detector/integrator vs transferrin concentration. Column: 5 x 0.5 cm. Conditions as in Fig. 2 Detection limit. Our lower limit of detection, defined as twice the response of a background signal of buffer injection, was 3 pg of TF (in Seronorm; 50 zL of a 60 mgfL solution).
Analytical recovery and interferences.
Recovery of TF (injected amounts:
100-120 pg) during the analytical procedure as presented in Figure 2 was 98% (SD 2%). There was no interference from major components of plasma such as albumin, as judged from injection of samples of purified protein. To further substantiate the specificity of the method, we subjected relevant fractions from chromatography of serum and purified transferrin samples to SDS-PAGE ( Figure  4) . The eluted fraction from injected serum yielded homogeneous transferrin bands with minimum interference of contaminating substances (purity: >95%). No detectable transferrin was found in the unbound fraction (data not shown). The estimated Mr of TF from SDS-PAGE is in the range of 74000-79000, which is in accordance with published values (M 81000).
Precision. Intra-and interassay variations were evaluated ( Table 1) Comparison with RIE for measurement of TF in serum. As a critical test of the wic method, we performed a comparative study with RIE, an established clinical method in Sweden for measuring TF in serum/plasma.
As shown in Figure 5 , correlation between the two methods was high (r (1-2 mm) . Stability. We estimated the stability of the m'IAC columns by measuring the operational binding capacity after various periods of operation. We found that the 10-cm iIpi.Ac column showed no decrease in its capacity to bind TF after about 240 cycles, with pH drops to 1.6-2.4. However, this 5-cm upiAc column, which was used at pH 1.3, showed a 30% loss in capacity after -500 cycles during a period of two months. The reason for this decrease is not known, but could involve microbial contamination, denaturing conditions during operation, and (or) leakage of ligand from the support. During the 500 cycles the inlet filter was replaced only once. It is important to note,however, that the analytical performance of the m'ic system during operation had not altered, i.e., the separation proffle was the sameafter about 500 injections of serum samples, because only about 20% of the total capacity of the column had been utilized. Thus, by using m'IAc-columns with an "excess" of antibody ligands, operational column life will be extended considerably. Only when the loss in binding capacity is large enough to make the remaining binding sites unable to adsorb the sample will there be a significant change in performance.
We show here that lwIAc can be used as a tool for rapid quantitative analysis of biomolecules in crude samples. Compared with various immunoassays, the main advantages of in'iAc include speed of analysis, especially in the case of a limited number of samples, and simple handling of samples. The latter is of special importance in judging the total economy of the analytical procedure.
In addition, HPLAC may offer additional advantages such as the availability of a purified substance that can be used for further characterization. As polyclonal and monoclonal antibodies to most biomolecules become available and as activated supports for m'IAc and HPLC instrumentation that is well adapted for automated operation are introduced, there should be great opportunities to design other efficient analytical HPLC systems based on bioaflinity interactions.
Measurement of biomolecules by HPLAC is of great interest not only in clinical chemistry but also in process control, where there is need for rapid, reliable monitoring of metabolites (e.g., the production of interferon and tissue plasminogen activator in industrial biotechnology).
